© 2019 Tyrosinemia Society, Inc.

Dr. Rani H. Singh

Ph.D.

Medical/Scientific Advisory Board Member

Dr. Rani H. Singh is Professor of Human Genetics and Pediatrics, and Director of the Genetic Metabolic Nutrition Program at the Emory University School of Medicine in Atlanta, Georgia, USA.


She obtained her PhD in Nutrition in 1989 at the University of Georgia, Georgia, USA and completed her Postdoctoral Fellowship at the Medical Genetics Division in the Department of Pediatrics at the Emory University in Atlanta, Georgia, USA.
 

With over 20 years of research and clinical experience in the field of inborn errors of metabolism (IEM), her clinical research interest focuses on the efficacy of restrictive diets and genotype/phenotype relationships. Her primary career interests have included maximizing the benefits of the early identification through newborn screening (NBS) and pre-symptomatic treatment with diets to improve health outcomes in children with IEM.


Prof. Singh has (co-)authored many publications and book chapters and has led nationally recognized efforts in developing translational clinical research. She is Principal Investigator (PI) of the Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB) funded project “Enhanced Genetic Services and Southeast Regional Genetics Network” which identifies gaps in genetic services. She has also served on the Board of the Society for Inherited Metabolic Disorders (SIMD) and as President of the Southeastern Regional Genetics Group (SERGG). In addition, she is the founding President of the Genetic Metabolic Dietitians International (GMDI), the leading PI for the Nutritional Management Guidelines Project, electronic Genetic Nutrition Academy (eGNA), and served as the Chair for the nutrition section of the phenylketonuria (PKU) Scientific Review Committee of the National Institute of Health. She recently received a grant from the State of Georgia Department of Public Health to develop the Medical Nutrition Therapy for Prevention (MNT for P) program for inherited metabolic disorders, which will not only improve access to genetic nutrition services, but also lead to development of a national model for long-term outcomes as they relate to nutrition interventions.